Our team is proud to share the promising news from multiple sponsors of recent IITRI in vivo studies. Links below to recent publications. Congrats all!
New Sponsor Publication from Mouse Influenza Studies at IITRI: Intranasal administration of a panreactive influenza antibody reveals Fc-independent mode of protection (Leyden Laboratories)
Nature Scientific Reports (04/08/2025)
New Sponsor Publication from NHP PK Studies at IITRI: Development and preclinical testing of a naloxone prodrug depot for extended protection against opioid overdose (University of the Pacific)
Nature Communications (01/23/2025)
IITRI continues to support many biotech, academic institutions, and small pharma to develop and test efficacy and safety of new drugs, including for infectious disease, gene therapy, and Schedule 1 drugs and treatments. Reach out to us today to discuss your program needs!
Recent Comments